Discover
LTRN
Lantern Pharma Inc.
2.03
2 x 1.44
2 x 2.67
bid
ask
-
0.04
1.93%
12:28 PM
timesize
| Ytd | -33.00% | |
| 1y | -50.25% |
2.00
day range
2.08
1.11
52 week range
4.70
| Open | 2.04 | Prev Close | 2.07 | Low | 2.00 | High | 2.08 | Mkt Cap | 25.95M |
| Vol | 37.00K | Avg Vol | 151.31K | EPS | -1.63 | P/E | N/A | Forward P/E | -1.50 |
| Beta | 2.34 | Short Ratio | 4.74 | Inst. Own | 24.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 3.00 | 200-d Avg | 2.96 | 1yr Est | 20.50 |
| Income Statement | |||
| Operating Expenses | 3.51M | ||
| Research and Development Expense | 1.79M | ||
| Selling, General and Administrative Expense | 1.72M | ||
| Operating Income | -3.51M | ||
| Net Income | -7.07M | ||
| Net Income Common Stock | -7.07M | ||
| Net Income Common Stock (USD) | -7.07M | ||
| Consolidated Income | -7.07M | ||
| Earnings per Basic Share | -0.57 | ||
| Earnings per Basic Share (USD) | -0.57 | ||
| Earnings per Diluted Share | -0.57 | ||
| Earning Before Interest & Taxes (EBIT) | -7.07M | ||
| Earning Before Interest & Taxes (USD) | -7.07M | ||
| Weighted Average Shares | 12.42M | ||
| Weighted Average Shares Diluted | 12.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.66M | ||
| Cash and Equivalents (USD) | 6.66M | ||
| Investments | 701.09K | ||
| Investments Current | 701.09K | ||
| Current Assets | 8.46M | ||
| Property, Plant & Equipment Net | 62.51K | ||
| Total Assets | 8.60M | ||
| Debt Current | 39.72K | ||
| Total Debt | 39.72K | ||
| Current Liabilities | 4.32M | ||
| Total Liabilities | 11.82M | ||
| Accumulated Retained Earnings (Deficit) | -103.55M | ||
| Accumulated Other Comprehensive Income | -39.76K | ||
| Shareholders Equity | -3.22M | ||
| Shareholders Equity (USD) | -3.22M | ||
| Assets Non-Current | 143.43K | ||
| Total Debt (USD) | 39.72K | ||
| Liabilities Non-Current | 7.50M | ||
| Trade and Non-Trade Payables | 4.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.38K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.74M | ||
| Net Cash Flow from Investing | 692.25K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 692.25K | ||
| Net Cash Flow from Operations | -2.94M | ||
| Effect of Exchange Rate Changes on Cash | -664.00 | ||
| Share Based Compensation | 285.26K | ||